Phase II Metastatic ER+/PgR+ Nolvadex +/- Iressa Study

PHASE2CompletedINTERVENTIONAL
Enrollment

317

Participants

Timeline

Start Date

October 31, 2003

Primary Completion Date

December 31, 2006

Study Completion Date

June 30, 2015

Conditions
Breast Neoplasms
Interventions
DRUG

Gefitinib

DRUG

Tamoxifen

Trial Locations (55)

Unknown

Research Site, Berkeley

Research Site, Palm Springs

Research Site, St Louis

Research Site, New York

Research Site, Bahía Blanca

Research Site, Ciudad de Buenos Aires

Research Site, Córdoba

Research Site, El Palomar

Research Site, Resistencia

Research Site, Rosario

Research Site, San Miguel de Tucumán

Research Site, Santa Fe

Research Site, Vicente López

Research Site, Bentleigh East

Research Site, Newcastle

Research Site, Randwick

Research Site, Westmead

Research Site, Wodonga

Research Site, Brussels

Research Site, Leuven

Research Site, Wilrijk

Research Site, Belo Horizonte

Research Site, Curitiba

Research Site, Porto Alegre

Research Site, São Paulo

Research Site, Calgary

Research Site, Edmonton

Research Site, Saint John

Research Site, Ottawa

Research Site, Toronto

Research Site, Montreal

Research Site, Québec

Research Site, Herlev

Research Site, Lyon

Research Site, Mougins

Research Site, Poitiers

Research Site, Rouen

Research Site, Frankfurt

Research Site, Jena

Research Site, Kiel

Research Site, München

Research Site, Trier

Research Site, Durban

Research Site, Johannesburg

Research Site, Klerksdorp

Research Site, Observatory

Research Site, Barcelona

Research Site, Córdoba

Research Site, Madrid

Research Site, Majadahonda

Research Site, Zaragoza

Research Site, Colchester

Research Site, Dundee

Research Site, Manchester

Research Site, Nottingham

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY